Keryx Biopharmaceuticals Inc. (KERX) Slipped -5.48% or -0.27 To Price $4.66 On Wednesday


Keryx Biopharmaceuticals Inc. (KERX) slipped -5.48% or -0.27 to $4.66. It is close to 1.57 million shares traded, which is 109.48% compare to the average total volume 1.44 million. The market cap of KERX is $555.58 million. The year to date change is 0.41%. The 52 week price range is from $4.33 to $8.38. Price of KERX have changed -0.20% during last week. It have changed 5.79% over last month, -14.85% over last 3 months, -32.37% over last 6 months and 0.72% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for KERX is 4.73. It is 1.50% above current price. The 200-day Moving Averages for KERX is 6.21. It is 33.26% above current price. The 52-week High is 8.38. It is 79.83% from the current price. The 52-week Low is 4.33. It is -7.08% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of KERX is 13.2 on 2017-12-29. Short % to float is 20.37%. There are some statistics of KERX. It is has market cap $555.58 million. The share outstanding is 119.22 million. The average volume is 1.44 million. The revenue is 51.49M. It has 457.25M cash and 250.00M in debt. The gross profit is 20.52M. The percent of top 15 Institution holding is 67.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of KERX is -1077.80%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of KERX is -97.41%.


Tags:

Share this post